Strategic Investment Fund

What Strategic Investment Fund does

Strategic Investment Fund (SIF) is the impact-first investment arm of the Bill & Melinda Gates Foundation, headquartered in Seattle with a regional office in London and a 17-person investment team. Founded in 2009 as Program-Related Investments (PRI) and rebranded to SIF in August 2018, the organization manages a $2.5 billion investment pool that has executed more than 100 investments across 40+ program strategies spanning six focus areas: Life Sciences, Healthcare Delivery, Agriculture & Nutrition, Inclusive Financial Systems, Women's Innovation, and U.S. Education & Opportunity. SIF deploys program-related capital through three primary instruments: direct equity investments (Series A and later), debt financing, and structured volume guarantees executed with multinational pharmaceutical partners such as Sanofi, Merck, Bayer, and Mylan.

SIF operates as a nonprofit rather than a return-maximizing fund. Its purpose is to advance the foundation's charitable goals by backing innovations that address market failures in low- and middle-income countries and underserved U.S. communities, with co-investment from both rate-of-return and impact-oriented partners. Investment minimums typically start at $5 million, with deal teams sourcing from the foundation's Global Development, Global Health, Gender Equality, U.S. Education, and Global Policy and Advocacy programs, supplemented by venture capital and ecosystem networks; unsolicited proposals are not accepted. Notable portfolio exposures include bKash (mobile money, 70M+ users), Kaleidofin (AI/ML credit scoring for low-income women), BioNTech (HIV/TB vaccines), Butterfly Network (handheld ultrasound), Immunocore (infectious disease biologics), CropIn Technology (agricultural SaaS), and M-KOPA (off-grid solar).

Commercial logic for SIF rests on three structural levers. First, its $2.5 billion fully committed pool and embedded position inside the Gates Foundation provide unlimited patient capital without external fundraising cycles or finite fund-life constraints; investment proceeds are recycled back into the foundation. Second, the Volume Guarantee program led by the Director of Volume Guarantees is structured to generate expected $1B+ in procurement savings for global health commodities. Third, SIF's portfolio spans both early-stage venture and structured-finance transactions, supporting global health infrastructure through partnerships with UNICEF, Gavi, the Global Fund, and the Serum Institute of India. Governance is anchored by an Investment Committee that combines internal Gates Foundation representatives with external advisers drawn from Frazier Life Sciences and Kodiyalam Capital.

Name

Strategic Investment Fund

Legal name

Strategic Investment Fund

Website

https://sif.gatesfoundation.org

Company type

Private

Founded year

2009

Operating status

Operating

Short description

Strategic Investment Fund is the impact-first investment arm of the Bill & Melinda Gates Foundation, deploying a $2.5B pool across life sciences, healthcare delivery, agriculture, financial inclusion, women's innovation, and U.S. education in underserved markets globally.

Ownership category

akta.pro rank

Product category

Impact Investment Fund / Strategic Investment Services

NAICS

Funds, Trusts, and Other Financial Vehicles (525), Other Investment Pools and Funds (5259)

SIC

Investors, Nec (6799)

akta.pro primary industry

SDG / Thematic Sustainable Investment Funds (FSANAJAN)

akta.pro secondary industries

Impact Investment & Development Investment Funds (BPADACAO), ESG Integration / Responsible Investment Funds (Broad ESG) (FSANAJAL)

Keywords

• Impact investment fund
• Program-related investments
• Volume guarantee financing
• Venture capital investments
• Philanthropic investment tools

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales, Technology or R&D

Revenue model

1. Strategic Investments: SIF makes strategic investments (equity, debt, guarantees) to support Gates Foundation's programmatic goals. Primary purpose is charitable impact, not income generation. Investment proceeds are recycled into the foundation upon exit, allowing continued grantmaking and strategic investments.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Strategic Investment Fund (SIF) is the impact-first investment arm of the Bill & Melinda Gates Foundation, deploying equity, debt, volume guarantees, and structured financing into companies advancing global health, agriculture, financial inclusion, education, and women's economic empowerment. With a $2.5 billion investment pool and 100+ investments to date, SIF typically invests $5 million or more per transaction and recycles proceeds back to the foundation.

Product overview

The Strategic Investment Fund (SIF) is the impact investment arm of the Gates Foundation, managing a $2.5 billion investment pool. SIF provides three primary investment tools: Volume Guarantees (structured transactions with suppliers for health products), Direct Equity Investments (Series A+ venture funding to private placements), and Debt Financing (loans and credit enhancements). The fund invests across six focus domains: Life Sciences, Healthcare Delivery, Agriculture & Nutrition, Inclusive Financial Systems, Women's Innovation, and U.S. Education & Opportunity. Key portfolio companies include Kaleidofin (AI/ML-powered fintech for women), CropIn (agricultural SaaS), Enko Chem (AI/ML for crop protection), Butterfly Network (handheld ultrasound), and various other companies in healthcare, biotech, and fintech sectors serving South Asia and Sub-Saharan Africa.

Differentiator

Problem solved

Functional benefit

Products and services

• Volume Guarantees Structured transactions with suppliers (pharmaceutical companies, manufacturers) to facilitate new product launches and secure adequate stock for developing countries at affordable prices. Partners include Sanofi, Merck, Bayer, and Mylan. Portfolio expected to generate $1B+ in procurement savings across vaccines, family planning, HIV, malaria, and nutrition commodities.
• Direct Equity Investments Equity funding from Series A+ to private placements, provided to impact-focused companies across life sciences, healthcare delivery, agriculture, financial services, and education. Typically $5 million or more per investment; aligned with the foundation's programmatic strategies and Global Access commitments.
• Debt Financing Loans and credit enhancements provided to companies advancing the foundation's programmatic goals, including subordinated bridge loans and innovative credit solutions for underserved markets and high-impact enterprises.
• Biotech Accelerator Program SIF's biotech-focused accelerator supporting early-stage life sciences companies developing therapeutics, vaccines, and platform technologies for global health, including HIV, TB, malaria, and other LMIC disease priorities.

Quantifiable outcome

• 70M+ mobile money customers served through bKash
• +4 more outcomes

Named customers10 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Gates Foundation Program TeamscoreStrategic or Co-development Partner · 1 January 2009SIF works directly with Gates Foundation's program teams - Global Development, Global Growth and Opportunity, Global Health, Gender Equality, U.S. Education, and Global Policy and Advocacy - to identify investment opportunities that produce greatest impact. This partnership allows investments to best support foundation's programmatic strategies.
• UNICEFcoreStrategic or Co-development PartnerVaccine Independence Initiative allows countries to bridge finance vaccine procurement. Multiple investments with UNICEF VII supporting vaccines, malaria and COVID-19 commodities, and nutrition.
• Gavi, The Vaccine AlliancecoreStrategic or Co-development PartnerPartnership with Gavi and Serum Institute of India to accelerate manufacture and delivery of COVID-19 vaccines for low- and middle-income countries (up to 200M doses).
• Pharmaceutical CompaniescoreStrategic or Co-development PartnerVolume guarantees executed with pharmaceutical companies to facilitate new product launches and secure adequate stock for developing countries at affordable prices. Partners include Sanofi, Merck, Bayer, Mylan, and others.
• McKinsey & CompanyminorOthersPrior employer of Natalie Revelle where she served high tech clients on strategy development, procurement, and pricing.
• The Global FundcoreStrategic or Co-development PartnerVolume guarantee to accelerate access to new, high-quality HIV, tuberculosis, and malaria products.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• KfW Development Bank: German state development bank providing structured finance, guarantees, and equity for development projects. Comparable in deploying catalytic capital through volume guarantees and structured financing, particularly in global health commodities.
• British International Investment (BII): UK's development finance institution, making direct equity, debt, and fund investments across Africa and South Asia. Comparable in geographic focus and use of structured capital to catalyze private investment in LMICs.
• International Finance Corporation (IFC): World Bank Group's private-sector development finance arm, deploying equity, debt, and guarantees in emerging markets. Comparable as a large-scale, multi-tool investor in healthcare, agriculture, and fintech across SIF's target geographies, though broader in scope and capital base.
• TPG Rise: Impact-focused private equity platform of TPG investing across climate, healthcare, and education globally. Comparable as a commercial impact investor pursuing both returns and measurable social outcomes, though structured as a traditional PE platform.
• US International Development Finance Corporation (DFC): US government's development finance institution providing debt, equity, and political risk insurance in emerging markets. Comparable as a large, multi-tool impact investor with overlapping geographies and sectors to SIF.

Direct peers

• Omidyar Network: Philanthropic impact investment firm founded by eBay's Pierre Omidyar that deploys equity, debt, and guarantees across financial inclusion, education, and governance. Directly comparable to SIF as a mission-driven, multi-tool impact investor of similar scale and structure.
• Acumen: Nonprofit impact investment fund backing entrepreneurs in agriculture, energy, and health across South Asia and Sub-Saharan Africa. Closely comparable to SIF in geographic focus, sector mix, and use of patient capital to address market failures for low-income populations.
• Skoll Foundation: Foundation that combines grantmaking and impact investing to scale social enterprises. Comparable to SIF as a foundation-driven impact investor backing entrepreneurs in health, education, and economic opportunity.
• Children's Investment Fund Foundation (CIFF): Major philanthropic foundation with a dedicated climate, health, and education investment function. Closely comparable to SIF in deploying programmatic capital (including structured finance and volume guarantees) for measurable outcomes in LMICs.
• Wellcome Trust Investments: Investment division of a large UK charitable foundation that deploys endowment capital into life sciences, biotech, and global health ventures. Directly comparable as a foundation-backed impact/PRI vehicle with a strong life sciences focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strategic Investment Fund